ES2104700T3 - Compuestos farmaceuticos de funciones multiples y metodos de utilizacion. - Google Patents

Compuestos farmaceuticos de funciones multiples y metodos de utilizacion.

Info

Publication number
ES2104700T3
ES2104700T3 ES91908058T ES91908058T ES2104700T3 ES 2104700 T3 ES2104700 T3 ES 2104700T3 ES 91908058 T ES91908058 T ES 91908058T ES 91908058 T ES91908058 T ES 91908058T ES 2104700 T3 ES2104700 T3 ES 2104700T3
Authority
ES
Spain
Prior art keywords
compounds
novel
methods
pharmaceutical compounds
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91908058T
Other languages
English (en)
Inventor
Alvin J Glasky
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2104700T3 publication Critical patent/ES2104700T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

SE PRESENTAN NUEVOS COMPUESTOS FARMACEUTICOS MULTIFUNCIONALES QUE INCORPORAN AL MENOS DOS MOLECULAS ESTRUCTURALES DE QUIMICA BIOLOGICAMENTE ACTIVA UNIDAS MEDIANTE AL MENOS UN GRUPO PUENTE QUIMICO. LAS MOLECULAS QUIMICAS SE ESCOGEN PARA EXHIBIR ACTIVIDAD BIOLOGICA ESPECIFICA, INCLUYENDO ACTIVIDAD INMUNOLOGICA, ACTIVIDAD NEUROLOGICA, ACTIVIDAD CARDIOVASCULAR Y ACTIVIDAD ANTIMICROBIANA. LOS COMPUESTOS FARMACEUTICOS MULTIFUNCIONALES EXHIBEN PROPIEDADES BIOLOGICAS SINERGISTICAS, QUE DEPENDEN UNICAMENTE DE LA DOSIS Y SON PARTICULARMENTE UTILES PARA EL TRATAMIENTO FISIOLOGICOS INTERELACIONADOS.
ES91908058T 1990-03-28 1991-03-26 Compuestos farmaceuticos de funciones multiples y metodos de utilizacion. Expired - Lifetime ES2104700T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/500,789 US5091432A (en) 1990-03-28 1990-03-28 9-substituted hypoxanthine bi-functional compounds and their neuroimmunological methods of use

Publications (1)

Publication Number Publication Date
ES2104700T3 true ES2104700T3 (es) 1997-10-16

Family

ID=23990941

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91908058T Expired - Lifetime ES2104700T3 (es) 1990-03-28 1991-03-26 Compuestos farmaceuticos de funciones multiples y metodos de utilizacion.

Country Status (17)

Country Link
US (1) US5091432A (es)
EP (1) EP0522082B1 (es)
JP (1) JP3198335B2 (es)
KR (1) KR100194162B1 (es)
AT (1) ATE154880T1 (es)
AU (1) AU7678191A (es)
CA (1) CA2079342C (es)
CS (1) CS85991A3 (es)
DE (1) DE69126701T2 (es)
DK (1) DK0522082T3 (es)
ES (1) ES2104700T3 (es)
GR (1) GR3024904T3 (es)
IE (1) IE81123B1 (es)
IL (1) IL97638A (es)
NZ (1) NZ237574A (es)
TW (1) TW279865B (es)
WO (1) WO1991014434A1 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5447939A (en) * 1994-07-25 1995-09-05 Glasky; Alvin J. Carbon monoxide dependent guanylyl cyclase modifiers and methods of use
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
NZ291592A (en) 1994-07-25 2001-03-30 Michel P Rathbone Use of carbon monoxide dependent guanylyl cyclase modulating purine derivative for treating neurological diseases
US5801184A (en) * 1994-07-25 1998-09-01 Glasky; Alvin J. Carbon monoxide dependent guanylyl cyclase modifiers and methods of use
US20020022657A1 (en) * 1998-02-11 2002-02-21 Francine Gervais Methods for modulating neuronal cell death
WO1999057119A1 (en) * 1998-05-04 1999-11-11 Neotherapeutics, Inc. Novel dopamine-like 9-substituted hypoxanthine and methods of use
US6303617B1 (en) * 1998-05-04 2001-10-16 Neotherapeutics, Inc. Serotonin-like 9-substituted hypoxanthine and methods of use
US6297226B1 (en) 1999-10-15 2001-10-02 Neotherapeutics, Inc. Synthesis and methods of use of 9-substituted guanine derivatives
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
WO2001039723A2 (en) * 1999-12-06 2001-06-07 Euro-Celtique, S.A. Triazospiro compounds having nociceptin receptor affinity
US6407237B1 (en) * 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) * 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
ES2385931T3 (es) 2000-07-07 2012-08-03 Spectrum Pharmaceuticals, Inc. MÉTODOS PARA EL TRATAMIENTO DE NEUROPATíA PERIFÉRICA INDUCIDA POR UNA ENFERMEDAD Y AFECCIONES RELACIONADAS.
WO2002004449A2 (en) * 2000-07-07 2002-01-17 Neotherapeutics, Inc. Methods for treatment of conditions affected by activity of multidrug transporters
US20020040032A1 (en) * 2000-07-07 2002-04-04 Glasky Michelle S. Methods for stimulation of synthesis of synaptophysin in the central nervous system
US20020040031A1 (en) * 2000-07-07 2002-04-04 Glasky Michelle S. Methods for prevention of accumulation of amyloid beta peptide in the central nervous system
WO2002058736A2 (en) * 2000-12-12 2002-08-01 Neotherapetics, Inc. Use of 9-substituted purine analogues and other molecules to stimulate neurogenesis
US6759427B2 (en) 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20020156277A1 (en) * 2001-04-20 2002-10-24 Fick David B. Synthesis and methods of use of purine analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
US6906190B2 (en) * 2002-01-04 2005-06-14 Ribapharm Inc. Inhibitors for de novo-RNA polymerases and methods of identifying targets for same
NZ546887A (en) 2003-11-03 2009-04-30 Probiodrug Ag Combinations useful for the treatment of neuronal disorders
US7473728B2 (en) * 2004-12-16 2009-01-06 The Goodyear Tire & Rubber Company Dual phase rubber composition and tire with nanocomposite-containing sidewall thereof
CA2900876A1 (en) 2004-12-22 2006-08-17 Bhi Limited Partnership Methods and compositions for treating amyloid-related diseases
ATE481094T1 (de) * 2005-12-22 2010-10-15 Kiacta Sarl Behandlung von diabetischer nephropathie
KR101443573B1 (ko) 2006-10-12 2014-11-03 비에이치아이 리미티드 파트너쉽 3-아미노-1-프로판설폰산을 전달하기 위한 방법, 화합물, 조성물 및 비히클
AU2007337806A1 (en) * 2006-12-22 2008-07-03 Bellus Health (International) Limited Methods, compounds, and compositions for treating metabolic disorders and diabetes
ES2916805T3 (es) * 2012-11-21 2022-07-06 Zoetis Services Llc Síntesis de derivados de isoxazolina espirocíclicos
CN115521306B (zh) * 2022-09-26 2024-03-26 贵州大学 一种1,2,3,4-四氢-β-咔啉衍生物及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3321369A (en) * 1965-05-26 1967-05-23 Abbott Lab Method of enhancing learning rate and retention level in warm blooded animals
US3484521A (en) * 1966-06-23 1969-12-16 Int Chem & Nuclear Corp Enhancement of memory processes in mammals with basic addition salts of ribonucleic acid
US4221910A (en) * 1978-09-15 1980-09-09 Newport Pharmaceuticals International, Inc. 9-(Hydroxy alkyl)purines
US4221909A (en) * 1978-09-15 1980-09-09 Sloan-Kettering Institute For Cancer Research P-Acetamidobenzoic acid salts of 9-(hydroxyalkyl) purines
US4221794A (en) * 1979-06-21 1980-09-09 Newport Pharmaceuticals International, Inc. Method of imparting immunomodulating and antiviral activity
IL64501A (en) * 1980-12-22 1985-07-31 Astra Laekemedel Ab 9-substituted 4-hydroxybutyl guanine derivatives,their preparation and antiviral use
US4728605A (en) * 1984-07-31 1988-03-01 Fudenberg Herman H Methods for recognizing and diagnosing subsets of Alzheimer's disease associated with immune system dysfunction, and for the in vitro testing of possible therapeutic agents for treatment of same
US4952693A (en) * 1984-10-12 1990-08-28 Warner-Lambert Company Oxazolo-pyrimidine derivatives

Also Published As

Publication number Publication date
AU7678191A (en) 1991-10-21
DE69126701D1 (de) 1997-08-07
JPH05508390A (ja) 1993-11-25
ATE154880T1 (de) 1997-07-15
IL97638A0 (en) 1992-06-21
DK0522082T3 (da) 1997-07-21
WO1991014434A1 (en) 1991-10-03
DE69126701T2 (de) 1997-12-04
EP0522082A4 (en) 1993-06-09
CA2079342C (en) 2001-10-23
IE910994A1 (en) 1991-10-09
EP0522082B1 (en) 1997-07-02
GR3024904T3 (en) 1998-01-30
IL97638A (en) 1999-03-12
CA2079342A1 (en) 1991-09-29
TW279865B (es) 1996-07-01
CS85991A3 (en) 1992-02-19
NZ237574A (en) 1993-09-27
US5091432A (en) 1992-02-25
EP0522082A1 (en) 1993-01-13
KR100194162B1 (ko) 1999-06-15
JP3198335B2 (ja) 2001-08-13
IE81123B1 (en) 2000-03-22

Similar Documents

Publication Publication Date Title
ES2104700T3 (es) Compuestos farmaceuticos de funciones multiples y metodos de utilizacion.
NL300224I1 (nl) 3-Benzazepinzonen gesubstitueerd met een benzocyclobutyl-of indanylalkyla-minoalkylgroep, bruikbaar voor de behandeling van cardiovasculaire aandoeningen.
ES2102475T3 (es) Nuevas alquil-amidas heterociclicas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
AU1808488A (en) Compounds for the treatment of alzheimer's disease
ES2087625T3 (es) Derivados de ciclohexano sustituidos, procedimiento para su preparacion y el empleo de los compuestos para el tratamiento de enfermedades.
ES2193246T3 (es) Cefalosporinas antibacterianas.
FI900760A0 (fi) Benzensulfonamider och foerfarande foer deras framstaellning.
EP0387821A3 (de) 2-Alkyl-4-arylmethylaminochinoline, ihre Verwendung und daraus hergestellte Arzneimittel
KR920002151A (ko) 15-케토-프로스타글란딘 화합물에 의한 염증성 질환 치료
MC1930A1 (fr) Produit antiviral
FI902901A0 (fi) Dibenzol/1,5/dioxocin-5-one-derivat, deras anvaendning i laekemedel och foerfarande foer deras framstaellning.
KR920003972A (ko) 프로스타시클린 화합물을 이용한 백내장 치료
PT89582A (pt) Processo para a preparacao de antibioticos beta-lactamicos uteis como medicamentos
MX9102181A (es) Iminobenzodiazepina para el tratamiento de desordenes del sueno
FI911616A0 (fi) Substituerade 3-tia- eller 3-oxa-alkyl -flavoner, foerfarande foer deras framstaellning, deras anvaendning, pao dessa foereningar baserade laekemedel samt mellanprodukter.
IT1265314B1 (it) Acilsulfammidi ad attivita' antitumorale
DK159184A (da) Pterinforbindelser
IT9067821A0 (it) Piastra complementare del tavolo chirurgico
IT1270054B (it) Composti ad attivita' ipocolesterolemica
IT1243948B (it) Sali di glicosamminoglicani
ZA917273B (en) Use of n-(1-hexahydroazepinylalkyl)acetamides in the preparation of medicaments for the treatment of cholinergic transmission disorders

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 522082

Country of ref document: ES